ProCE Banner Activity

Personalized Treatment Options From 5 Experts for People With CLL


Use this Interactive Decision Support Tool to see treatment options from 5 experts based on information about your cancer.

Released: October 17, 2022

Expiration: October 16, 2023

No longer available for credit.



Farrukh Awan

Farrukh Awan, MD, MS

Associate Professor of Internal Medicine
Division of Hematology
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

Jennifer R. Brown

Jennifer R. Brown, MD, PhD

Director, CLL Center & Institute Physician
Dana-Farber Cancer Institute
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Boston, Massachusetts

Jeff DONOTUSESharman

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

Nicole Lamanna

Nicole Lamanna, MD

Associate Professor
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York

Anthony Mato

Anthony Mato, MD, MSCE

Associate Professor
Division of Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from

AbbVie Inc.


Eli Lilly

Janssen Biotech

Pharmacyclics an AbbVie Company

TG Therapeutics


CLL Society

ProCE Banner

Additional Information

Program Medium

This program has been made available online.